drugset / Trial / NCT00555880

Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension

NCT00555880

Phase 4 Completed 24 enrolled Shire
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this clinical study is to evaluate the clinical effect of midodrine hydrochloride (ProAmatine®) compared to placebo in patients with orthostatic hypotension by measuring the time to onset of near syncopal symptoms and assessing several cardiovascular measurements, such as heart rate, blood pressure, and ECG, using the tilt table test.

Timeline

Start
2004-09-08
Primary completion
2005-03-21
Completion
2005-03-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Midodrine Small molecule 10 mg Oral
Subject Midodrine Small molecule 30 mg Oral